☆ 4.6 Article

Predictors of Postacute Sequelae of COVID-19 Development and Rehabilitation: A Retrospective Study

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2022)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study

Oscar Moreno-Perez et al.

Summary: This study found that Post-acute COVID-19 syndrome was detected in about half of COVID-19 survivors, with mostly mild symptoms. Radiological and spirometric changes were observed in less than 25% of patients, and no baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development.

JOURNAL OF INFECTION (2021)

Add to Collection

Letter Virology

COVID-19 related fatigue: Which role for rehabilitation in post-COVID-19 patients? A case series

Francesco Ferraro et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Add to Collection

Article Computer Science, Artificial Intelligence

NLP Methods for Extraction of Symptoms from Unstructured Data for Use in Prognostic COVID-19 Analytic Models

Greg M. Silverman et al.

JOURNAL OF ARTIFICIAL INTELLIGENCE RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Add to Collection

Review Rehabilitation

Rehabilitation and COVID-19: a rapid living systematic review by Cochrane Rehabilitation Field updated as of December 31st, 2020 and synthesis of the scientific literature of 2020

Alessandro de Sire et al.

Summary: This study summarizes the latest research on the rehabilitation of COVID-19 patients in 2020, finding that most studies are still at a lower level of evidence, but there is a gradual increase in research on chronic symptoms and long-term consequences of the infection.

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

A fast, resource efficient, and reliable rule-based system for COVID-19 symptom identification

Himanshu S. Sahoo et al.

Summary: The rule-based gazetteer developed in this study showed superior speed, resource utilization, and performance, providing an effective solution for real-time symptom identification and integration of unstructured data elements into clinical decision support systems. Fine-tuning lexical rules and running on multiple compute nodes were identified as opportunities to further enhance its performance.

JAMIA OPEN (2021)

Add to Collection

Article Critical Care Medicine

The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study

Carol L. Hodgson et al.

Summary: The study on COVID-19 critical illness patients showed that at six months, there was a substantial incidence of death and new disability, with over a third of survivors experiencing new disabilities. Health-related quality of life decreased among survivors, highlighting the long-term impact of COVID-19 critical illness.

CRITICAL CARE (2021)

Add to Collection

Article Medicine, General & Internal

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19

Michael A. Puskarich et al.

Summary: The study found that losartan did not reduce hospitalizations in low-risk outpatients with mild symptomatic COVID-19, and viral load was not affected by the treatment. This suggests that initiation of losartan treatment for this group is not supported.

ECLINICALMEDICINE (2021)

Add to Collection

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

Add to Collection

Article Infectious Diseases

Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients

Nicholas E. Ingraham et al.

SURGICAL INFECTIONS (2020)

Add to Collection

Article Cell Biology

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Bolin Wang et al.

AGING-US (2020)

Add to Collection

Review Respiratory System

Understanding the renin angiotensin-aldosterone-SARS-CoV axis: a comprehensive review

Nicholas E. Ingraham et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Critical Care Medicine

Antihypertensive drugs and risk of COVID-19?

Christopher J Tignanelli et al.

Lancet Respiratory Medicine (2020)

Add to Collection

Editorial Material Critical Care Medicine

Immunomodulation in COVID-19

Nicholas E. Ingraham et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

Neil Mehta et al.

JAMA CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19

Harmony R. Reynolds et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

National Trends and Variation of Functional Status Deterioration in the Medically Critically Ill*

Nicholas E. Ingraham et al.

CRITICAL CARE MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Persistent Symptoms in Patients After Acute COVID-19

Angelo Carfi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients

Natesan Vasanthakumar

BIOESSAYS (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Management of post-acute covid-19 in primary care

Trisha Greenhalgh et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

News Item Multidisciplinary Sciences

COVID-19'S LASTING MISERY

Michael Marshall

NATURE (2020)

Add to Collection

Editorial Material Medicine, General & Internal

A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection Illness Beyond Acute Infection and Public Health Implications

S. Deblina Datta et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.